Also listed under Neurocognitive Disorders
Dementia clinical trials
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-08
What changed in the last 30 days
133 trials changed in the last 30 days: 3 stopped, 60 with notable changes, 70 with minor changes only.
-
Minor: 11 trials marked Unknown by the registry's verification sweep Changed
- Minor: SANDY · Innovative Method in SAliva Samples for the Early Differential Diagnosis of High-impact NeuroDegenerative Diseases Through Raman Spectroscopy Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Enrolling by Invitation
- Minor: DROM-test · Decision Support Tool for Assessing the Ability to Decide on Returning Home · Cognitive Impairments Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Not Yet Recruiting
- Minor: CONSTELLATIONS Living Lab: Improving the Care Transitions · Neurocognitive Disorders Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Recruiting
- Minor: RCTCogRehab · Multidimensional Rehabilitation Programs for Cognitive Impairment in Comorbid Outpatients: a Randomized Controlled Trial Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Recruiting
- Minor: SIM-2 · Shanghai Non-pharmacological Intervention for Mild Cognitive Impairment and Mild Alzheimer's Disease Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Recruiting
- Minor: RJNB-AD · Ruijin Neurobank of Alzheimer's Disease and Dementia Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Recruiting
- Minor: AMUSED · Adherence by Music to Exercise in Dementia: Group Therapy Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Recruiting
- Minor: Psychometric Evaluation · Brain Damage During Neuroinflammation Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Enrolling by Invitation
- Minor: REMINDER · Validation of the REMINDER Dementia Risk Reduction Program Changed Registry marked status Unknown (sponsor has not verified the record since May 2024); last known: Recruiting
- Minor: Longitudinal Study Examining At-Home tDCS Changed Registry marked status Unknown (sponsor has not verified the record since Aug 2024); last known: Recruiting
- Minor: Warmth and Transcutaneous Electrical Nerve Stimulation (TENS) in Improving Cognitive Functions · Dementia Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Recruiting
- Notable: Interleukine-2 (IL-2) Plus Semaglutide in Alzheimer's Disease Primary endpoint(s) modified
- Notable: Acupressure as Long-term Intervention to Slow the Progression of Early/Mild Alzheimer's Disease Primary endpoint(s) modified
- Notable: NAB-IT · Nabilone for Agitation Blinded Intervention Trial Primary and study completion pushed from Apr 2027 to Dec 2027
- Notable: TARBELA-AD · Effects and Safety of RO7568282 in Early Symptomatic Alzheimer's Disease Recruitment opened
- Notable: BIOMARK-PS · Molecular Biomarkers for Differentiating Parkinsonian Syndromes Enrolling by invitation only
- Notable: SIRENS · Technology-Based Intervention Pilot Testing Recruitment opened
- Notable: LEAD · Locus-coeruleus Function in Normal Elderly and AD Risk Results posted: Nov 6, 2026
- Minor: PRIM-A · Prediction of Effectiveness of rTMS Application in Alzheimer's Patients Trial completed
- Minor: PrevenTRON · Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's Disease Trial sites expanded: 34 → 72 locations
- Minor: TREMHANCE · SAR448851 · Early Alzheimer's Disease Trial sites expanded: 20 → 32 locations
- Notable: Flutemetamol F 18 Injection Formulation Comparison Recruitment opened
- Notable: Smartphone Application Intervention in Community Settings: A Pretest-Posttest Pilot Study Recruitment opened
- Notable: Autonomy · JNJ-63733657 · Early Alzheimer's Disease Results posted: Nov 5, 2026
- Minor: Health enSuite Caregivers: an App-based Treatment for Distressed Caregivers · Moderate Dementia Trial status changed: Not Yet Recruiting → Active, Not Recruiting
- Minor: ACP-204 · Alzheimer's Disease Psychosis Trial sites expanded: 152 → 155 locations
- Minor: Master Protocol Studying Multiple Amyloid-Targeting Therapies in Healthy Participants and · Alzheimer's Disease Trial sites expanded: 16 → 19 locations
- Minor: Prediction and Prevention of Postoperative Mortality and Morbidity Start date pushed from Oct 2026 to Nov 2026
- Notable: VOCALE LBD · Online Peer Support for Caregivers · Lewy Body Dementia Recruitment opened
- Notable: Role of Gait Analysis in Different Type of Dementia Primary endpoint(s) modified
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
New sponsor entrants, last 90 days sponsors with their first trial in this area
| First posted | Trial | Sponsor | Phase |
|---|---|---|---|
| 2026-11-05 | NCT07918638 Prospective Research on Identification of Dementia in Early Stages (P.R.I.D.E) | Don Mottola Medical Center new | |
| 2026-11-03 | NCT07912710 China HEalthy Aging and Dementia Study (HEAD) | Fudan University new | |
| 2026-10-30 | NCT07907042 Effects of Doll Therapy on Apathy and Activities of Daily Living Initiation Deficits in… | Xinyu ZHANG new | |
| 2026-10-30 | NCT07905872 Feasibility of Community Occupational Therapy for Dementia (COT-D) | University of Vic - Central University of Catalonia new | |
| 2026-10-29 | NCT07905352 A Phase 2 Clinical Study of Simenafil Hydrochloride Tablets in the Treatment of… | Vigonvita Life Sciences new | Phase 2 |
| 2026-10-23 | NCT07892651 MENA/Levant Epidemiological, Registry of Immunological & Clinical Traits (MERIT) | Axiom Bioregistry new | |
| 2026-10-22 | NCT07890207 Human-LLM Conversations as a Digital Signature of Cognitive Performance in Adults | Technion, Israel Institute of Technology new | |
| 2026-10-22 | NCT07889349 A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of SHR 3201 Injection… | Beijing Suncadia Pharmaceuticals Co., Ltd new | Phase 1 |
| 2026-10-02 | NCT07856043 [11C]PS13 PET Imaging of Neuroinflammation in Heart Failure With Reduced Ejection Fraction | Stony Brook University new | Phase 1 |
| 2026-10-02 | NCT07854327 Restoring Cervical Lymphatic Drainage in Alzheimer's Disease | University of Siena new |
Active trials by phase
| Early Phase 1 | 21 | |
| Phase 1 | 76 | |
| Phase 1/2 | 50 | |
| Phase 2 | 138 | |
| Phase 2/3 | 18 | |
| Phase 3 | 70 | |
| Phase 4 | 32 |
Not charted: 1,109 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Top sponsors by active trials in this area
Xuanwu Hospital, Beijing (24) · Eli Lilly and Company (19) · Mayo Clinic (19) · Washington University School of Medicine (19) · Johns Hopkins University (17) · Massachusetts General Hospital (15) · Assistance Publique - Hôpitaux de Paris (14) · Indiana University (13) · Chang Gung Memorial Hospital (12) · The University of Hong Kong (12)
Get alerts when Dementia trials change
Status changes, date slips, and new sponsor entrants: detected daily, delivered to your inbox.